Treatment of murine Fusarium verticillioides infection with liposomal amphotericin B plus terbinafine

International Journal of Antimicrobial Agents

Volumn 37, Issue 1, 2011, Pages 58-61

  Ruíz Cendoya, Mery ^a   Pastor, F Javier ^a   Capilla, Javier ^a   Guarro, Josep ^a  

^a FACULTAT DE MEDICINA I CIÈNCIES DE LA SALUT   (Spain)

Author keywords

Fusarium verticillioides; Liposomal amphotericin B; Terbinafine

Indexed keywords

AMPHOTERICIN B LIPID COMPLEX; TERBINAFINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; CONFERENCE PAPER; CONTROLLED STUDY; DRUG EFFICACY; FUNGAL STRAIN; FUNGUS CULTURE; FUNGUS GROWTH; FUNGUS ISOLATION; FUSARIOSIS; FUSARIUM; FUSARIUM VERTICILLIOIDES; IN VITRO STUDY; INCUBATION TIME; MALE; MINIMUM INHIBITORY CONCENTRATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; SURVIVAL TIME;

AMPHOTERICIN B; ANIMALS; ANTIFUNGAL AGENTS; COLONY COUNT, MICROBIAL; DISEASE MODELS, ANIMAL; DRUG THERAPY, COMBINATION; FUSARIUM; KIDNEY; MALE; MICE; MYCOSES; NAPHTHALENES; SPLEEN; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 78650293756     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijantimicag.2010.08.008     Document Type: Conference Paper

References (21)

1. M. Nucci, and E. Anaissie Fusarium infections in immunocompromised patients Clin Microbiol Rev 20 2007 695 704
2. M. Nucci, K.A. Marr, F. Queiroz-Telles, C.A. Martins, P. Trabasso, and S. Costa Fusarium infection in hematopoietic stem cell transplant recipients Clin Infect Dis 38 2004 1237 1242
3. K. O'Donnell, B.A. Sarver, M. Brandt, D.C. Chang, J. Noble-Wang, and B.J. Park Phylogenetic diversity and microsphere array-based genotyping of human pathogenic Fusaria, including isolates from the multistate contact lens-associated U.S. keratitis outbreaks of 2005 and 2006 J Clin Microbiol 45 2007 2235 2248
4. A.M. Tortorano, A. Prigitano, G. Dho, M.C. Esposto, C. Gianni, and A. Grancini Species distribution and in vitro antifungal susceptibility patterns of 75 clinical isolates of Fusarium spp. from northern Italy Antimicrob Agents Chemother 52 2008 2683 2685
5. M. Azor, J. Gene, J. Cano, D.A. Sutton, A.W. Fothergill, and M.G. Rinaldi In vitro antifungal susceptibility and molecular characterization of clinical isolates of Fusarium verticillioides (F. moniliforme) and Fusarium thapsinum Antimicrob Agents Chemother 52 2008 2228 2231
6. H.I. Nirenberg, and K. O'Donnell New Fusarium species and combinations within the Gibberella fujikuroi species complex Mycologia 90 1998 434 458 (Pubitemid 28273432)
7. J.A. Guzman-Cottrill, X. Zheng, and E.G. Chadwick Fusarium solani endocarditis successfully treated with liposomal amphotericin B and voriconazole Pediatr Infect Dis J 23 2004 1059 1061
8. S. Neuburger, G. Massenkeil, M. Seibold, C. Lutz, I. Tamm, and P. le Coutre Successful salvage treatment of disseminated cutaneous fusariosis with liposomal amphotericin B and terbinafine after allogeneic stem cell transplantation Transpl Infect Dis 10 2008 290 293
9. A. Rothe, M. Seibold, T. Hoppe, H. Seifert, A. Engert, and C. Caspar Combination therapy of disseminated Fusarium oxysporum infection with terbinafine and amphotericin B Ann Hematol 83 2004 394 397
10. M. Ortoneda, J. Capilla, F. Javier Pastor, I. Pujol, and J. Guarro In vitro interactions of licensed and novel antifungal drugs against Fusarium spp. Diagn Microbiol Infect Dis 48 2004 69 71 (Pubitemid 38167503)
11. Clinical and Laboratory Standards Institute. Reference method for broth dilution antifungal susceptibility testing of filamentous fungi; approved standard. 2nd ed. Document M38-A2. Wayne, PA: CLSI; 2008.
12. G.M. Eliopoulos, and R.C. Moellering Antimicrobial combinations V. Lorian, Antibiotics in laboratory medicine 3rd ed. 1991 Williams & Wilkins Baltimore, MD 432 492
13. Q.N. Sun, L.K. Najvar, R. Bocanegra, D. Loebenberg, and J.R. Graybill In vivo activity of posaconazole against Mucor spp. in an immunosuppressed-mouse model Antimicrob Agents Chemother 46 2002 2310 2312 (Pubitemid 34665939)
14. A. Alastruey-Izquierdo, M. Cuenca-Estrella, A. Monzon, E. Mellado, and J.L. Rodriguez-Tudela Antifungal susceptibility profile of clinical Fusarium spp. isolates identified by molecular methods J Antimicrob Chemother 61 2008 805 809
15. D.Y. Ho, J.D. Lee, F. Rosso, and J.G. Montoya Treating disseminated fusariosis: amphotericin B, voriconazole or both? Mycoses 50 2007 227 231
16. M. Ortoneda, J. Capilla, F.J. Pastor, I. Pujol, and J. Guarro Efficacy of liposomal amphotericin B in treatment of systemic murine fusariosis Antimicrob Agents Chemother 46 2002 2273 2275
17. E. Cofrancesco, C. Boschetti, M.A. Viviani, C. Bargiggia, A.M. Tortorano, and M. Cortellaro Efficacy of liposomal amphotericin B (AmBisome) in the eradication of Fusarium infection in a leukaemic patient Haematologica 77 1992 280 283
18. H.J. Dornbusch, W. Buzina, R.C. Summerbell, C. Lass-Florl, H. Lackner, and W. Schwinger Fusarium verticillioides abscess of the nasal septum in an immunosuppressed child: case report and identification of the morphologically atypical fungal strain J Clin Microbiol 43 2005 1998 2001
19. G. Tezcan, B. Ozhak-Baysan, A. Alastruey-Izquierdo, D. Ogunc, G. Ongut, and S.T. Yildiran Disseminated fusariosis caused by Fusarium verticillioides in an acute lymphoblastic leukemia patient after allogeneic hematopoietic stem cell transplantation J Clin Microbiol 47 2009 278 281
20. M. Hosseini-Yeganeh, and A.J. McLachlan Physiologically based pharmacokinetic model for terbinafine in rats and humans Antimicrob Agents Chemother 46 2002 2219 2228
21. I. Durand-Joly, S. Alfandari, Z. Benchikh, M. Rodrigue, A. Espinel-Ingroff, and B. Catteau Successful outcome of disseminated Fusarium infection with skin localization treated with voriconazole and amphotericin B-lipid complex in a patient with acute leukemia J Clin Microbiol 41 2003 4898 4900